The first CTI BioPharma trade was made in Q4 2017.
Since then Ken Griffin bought shares eight more times and sold shares on nine occasions. The investor completely sold their stake between Q3 2022 and Q2 2023.
Avg closing price
Price range
Sold -3.66 Thousand shares
Q2 2023
Avg closing price
$7.04
Price range
$4.08
-
$9.10
Sold 92.9% shares (-47.6 Thousand shares)
Q1 2023
Avg closing price
$5.19
Price range
$4.20
-
$6.01
Sold 89.5% shares (-439 Thousand shares)
Q4 2022
Avg closing price
$5.46
Price range
$4.45
-
$6.17
Sold 40.1% shares (-329 Thousand shares)
Q3 2022
Avg closing price
$6.23
Price range
$5.36
-
$7.43
Increased shares by 704.2% (+718 Thousand shares)
Q2 2022
Avg closing price
$5.12
Price range
$3.55
-
$6.27
Increased shares by 360.8% (+79.8 Thousand shares)
Q1 2022
Avg closing price
$2.98
Price range
$1.90
-
$5.23
Sold 68.3% shares (-47.6 Thousand shares)
Q4 2021
Avg closing price
$2.45
Price range
$1.44
-
$2.86
New holding (+69.7 Thousand shares)
Q3 2021
Avg closing price
$2.72
Price range
$2.25
-
$3.18
Sold -211 Thousand shares
Q2 2021
Avg closing price
$2.40
Price range
$2.16
-
$2.62
New holding (+211 Thousand shares)
Q1 2021
Avg closing price
$3.26
Price range
$2.68
-
$3.80
Sold -29.3 Thousand shares
Q2 2020
Avg closing price
$1.06
Price range
$0.88
-
$1.32
New holding (+29.3 Thousand shares)
Q1 2020
Avg closing price
$1.15
Price range
$0.69
-
$1.54
Sold -74.4 Thousand shares
Q1 2019
Avg closing price
$1.05
Price range
$0.90
-
$1.37
Increased shares by 68.1% (+30.1 Thousand shares)
Q4 2018
Avg closing price
$1.64
Price range
$0.73
-
$2.19
Increased shares by 71.7% (+18.5 Thousand shares)
Q3 2018